Hoffmann-La Roche: all 2,744 studies
Page 23 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Study of Lebrikizumab in Healthy Japanese and Caucasian VolunteersCompletedNCT01423318Phase 1
- Patient Reported Symptoms in Ovarian Cancer (PRECISION)CompletedNCT01422265
- A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy VolunteersCompletedNCT01418989Phase 1
- A Study of RO5285119 in Healthy VolunteersCompletedNCT01418963Phase 1
- A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy VolunteersCompletedNCT01418274Phase 1
- FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal CancerCompletedNCT01418222Phase 2
- A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819CompletedNCT01409369Phase 1
- A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal CancerCompletedNCT01399684Phase 2
- A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy SubjectsCompletedNCT01398293Phase 1
- A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With LisinoprilCompletedNCT01398267Phase 1
- A Study of RO5267683 in Healthy SubjectsCompletedNCT01398241Phase 1
- A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01397578Phase 2
- An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic LeukaemiaCompletedNCT01395615
- A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy VolunteersCompletedNCT01392755Phase 1
- An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)CompletedNCT01392729
- A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaCompletedNCT01392716Phase 2
- An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)CompletedNCT01392001
- A Study on the Interaction Between Danoprevir/Ritonavir and MethadoneCompletedNCT01389544Phase 1
- A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's LymphomaCompletedNCT01388959Phase 2
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDsCompletedNCT01388309
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)CompletedNCT01384461
- A Study of RO5458640 in Patients With Advanced Solid TumorsCompletedNCT01383733Phase 1
- A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01375842Phase 1
- An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01375478
- Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial InfarctionCompletedNCT01374321Phase 2
- A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis CCompletedNCT01371162Phase 1
- A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian SubjectsCompletedNCT01368926Phase 1
- A Study of RO4995819 in Combination With Citalopram in Healthy VolunteersCompletedNCT01367756Phase 1
- Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)CompletedNCT01366131Phase 2
- A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy VolunteersCompletedNCT01365403Phase 1
- A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous ChemotherapyCompletedNCT01364012Phase 3
- Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian CancerCompletedNCT01363947Phase 1
- Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid TumorsCompletedNCT01363024Phase 1
- Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid TumorsCompletedNCT01362374Phase 1
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or LymphomaCompletedNCT01359696Phase 1
- An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)CompletedNCT01358942
- A Study of RO6807952 in Patients With Diabetes Mellitus Type 2CompletedNCT01358929Phase 1
- A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid TumorsCompletedNCT01358903Phase 1
- A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838CompletedNCT01356550Phase 1
- Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's LymphomaCompletedNCT01356173Phase 1
- An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell CarcinomaCompletedNCT01351571
- Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01347983Phase 3
- A Study on the Effect of Food on the Pharmacokinetics of RO5428029 in Healthy VolunteersCompletedNCT01345942Phase 1
- An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)CompletedNCT01344889
- A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld SyringeCompletedNCT01344863Phase 1
- A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)CompletedNCT01343966Phase 2
- An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line TherapyCompletedNCT01343914
- An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular LymphomaCompletedNCT01340443
- A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to CetuximabWithdrawnNCT01338558Phase 3
- An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)CompletedNCT01338545
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Smoking Versus Non-Smoking Patients With Rheumatoid ArthritisCompletedNCT01337388
- A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination TherapyCompletedNCT01337375Phase 1
- Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT01336465Phase 2
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT01335958Phase 1
- An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerCompletedNCT01333007
- GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01332604Phase 1
- A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis CCompletedNCT01331850Phase 2
- A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary InterventionCompletedNCT01327183Phase 2
- A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal CancerCompletedNCT01326000Phase 2
- An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or DialysisCompletedNCT01309295
- A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular CarcinomaCompletedNCT01308723Phase 1
- A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent GlioblastomaCompletedNCT01308684Phase 1
- Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.CompletedNCT01302600Phase 2
- A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid TumorsCompletedNCT01301716Phase 1
- Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV InfectionCompletedNCT01297127
- A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)WithdrawnNCT01296971Phase 3
- A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins LymphomaCompletedNCT01290549Phase 1
- A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the TabletCompletedNCT01287091Phase 1
- Safety Extension Study of TRO19622 in ALSCompletedNCT01285583Phase 2/3
- An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisCompletedNCT01283399
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01283373Phase 1
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)CompletedNCT01283074
- A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)CompletedNCT01278134Phase 2
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid ArthritisTerminatedNCT01277328
- An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)TerminatedNCT01277133
- An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1)TerminatedNCT01277120
- A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT01277094Phase 1
- An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)TerminatedNCT01276405
- An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal CancerCompletedNCT01266564
- A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)CompletedNCT01258907Phase 2
- Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01258712Phase 3
- Prenatal Test for Fetal Aneuploidy DetectionCompletedNCT01256606
- Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT01254526Phase 1
- A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) SurgeryCompletedNCT01245634Phase 2
- A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 TabletCompletedNCT01240226Phase 1
- Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253CompletedNCT01237496Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)CompletedNCT01235585Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)CompletedNCT01235559Phase 3
- A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)CompletedNCT01235520Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of SchizophreniaCompletedNCT01234779Phase 2
- A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic AtrophyCompletedNCT01229215Phase 2
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or LymphomaCompletedNCT01226277Phase 1
- A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid ArthritisCompletedNCT01225393Phase 2
- An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)CompletedNCT01224093
- Study of CH5132799 Administered Orally in Patients With Advanced Solid TumorsCompletedNCT01222546Phase 1
- A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01220947Phase 2
- An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric CancerCompletedNCT01220934
- A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid ArthritisCompletedNCT01214733Phase 3
- An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)CompletedNCT01213485
- Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)CompletedNCT01211626Phase 1